Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beyond PSMA: The essential complementary role of MRI in staging prostate cancer with Low-PSMA expression phenotypes.

European journal of nuclear medicine and molecular imaging - 1 Feb 2026

Chen Ruohua, Wang Yining, Dong Liang, Zhao Haitao, Li Lianghua, Huang Gang, Liu Liu, Liu Jianjun

Abstract excerpt

PURPOSE: While prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is a highly sensitive modality for staging prostate cancer, a notable subset of patients presents with negative findings, leading to potential under-diagnosis. The incremental diagnostic value of multiparametric magnetic resonance imaging (mpMRI) in this specific cohort remains poorly defined. This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antigens, Surface

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Magnetic Resonance Imaging

Share to Neoplasm Staging

Share to Phenotype

Share to Positron Emission Tomography Computed Tomography

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 41111085
DOI: 10.1007/s00259-025-07588-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beyond PSMA: The essential complementary role of MRI in staging prostate cancer with Low-PSMA expression phenotypes.PMID 41111085Read ↗

When PSMA Is Not Enough: The Diagnostic Blind Spots of PSMA PET/CT and the Added Value of [¹⁸F]FDG in High-Risk Prostate Cancer: Dual-Tracer Cohort StudySemantic proximity Read ↗

Bivariate Diagnostic Paired Meta-Analysis at the Patient Level: Direct Validation of PSMA-PET against Conventional Imaging Across All T/N/M Staging Dimensions in Primary Intermediate- to High-Risk Prostate CancerSemantic proximity Read ↗

Optimizing Detection of Clinically Significant Prostate Cancer through Nomograms incorporating MRI, Clinical Features, and Advanced Serum BiomarkersSemantic proximity Read ↗

False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS.Semantic proximity Read ↗

Follow-up Analysis of Intermediate-risk Prostate Cancer Patients Staged With Psma PET/CTSemantic proximity Read ↗

Biomarkers in Localized Prostate Cancer: Towards a Personalized MedicineSemantic proximity Read ↗

Usefulness of Tissue Biomarkers versus Prostate-Spcific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical ProstatectomySemantic proximity Read ↗

Screening for prostate cancer using PSA with and without MRI: systematic reviews with meta-analysisSemantic proximity Read ↗

Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI- Driven BiomarkersSemantic proximity Read ↗

MRI-invisible prostate cancer and the tumor microenvironment: an intra- patient paired transcriptomic and immunohistochemical studySemantic proximity Read ↗

Combined radiomics and liquid biopsy reflect tumor biology towards multimodal non-invasive prostate cancer risk stratificationSemantic proximity Read ↗

Patterns of disease detection using 18F-DCFPyL PET/CT imaging in men with biochemical recurrence post prostatectomy being considered for salvage radiotherapy: a prospective trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.